An intergenic region of human chromosome 2 (2p25.3) harbors genetic variants which are among those most strongly and reproducibly associated with obesity. The gene closest to these variants is TMEM18, although the molecular mechanisms mediating these effects remain entirely unknown. Tmem18 expression in the murine hypothalamic paraventricular nucleus (PVN) was altered by changes in nutritional state. Germline loss of Tmem18 in mice resulted in increased body weight, which was exacerbated by high fat diet and driven by increased food intake. Selective overexpression of Tmem18 in the PVN of wild-type mice reduced food intake and also increased energy expenditure. We provide evidence that TMEM18 has four, not three, transmembrane domains and that it physically interacts with key components of the nuclear pore complex. Our data support the hypothesis that TMEM18 itself, acting within the central nervous system, is a plausible mediator of the impact of adjacent genetic variation on human adiposity.T he understanding of human obesity has benefited greatly from advances in molecular genetics. In addition to the identification of many mechanistically illuminating, highly penetrant monogenic disorders, genome-wide association studies (GWAS) have identified multiple common genetic variants strongly associated with body mass index (BMI) (1-5). Many of these loci are within, or close to, genes which, to date, have not been recognized to encode proteins with a role in the control of energy homeostasis. Of note, these genes show a strong preponderance to being highly expressed in the central nervous system, a finding which is congruent with the fact that monogenic disorders leading to obesity largely exert their effects through a disruption of the central control of appetite and energy balance (6). Murine models have proven to be highly useful in bridging the gap between the identification of a variant as being associated with an adiposity phenotype and the understanding of how that variant actually influences energy balance. For example, the robust correlation between BMI and polymorphisms in the first intron of the human fat mass and obesity-associated (FTO) gene has been followed by loss and gain of function studies in genetically modified mice, supporting the notion that a number of neighboring genes including IRX3 (which is the gene most likely mediating the effect of the human SNP), RPGRIP1L, and FTO itself can all play a role in the control of energy balance and body composition (7-13). A strong association between increased BMI and a region of human chromosome 2, near to the gene TMEM18, has been repeatedly demonstrated in both adults and children (2, 14-18). Like the genes in the vicinity of FTO, TMEM18 had not been recognized as having a role in energy homeostasis before its identification by GWAS, and relatively little is known about its function, save that it is expressed in the brain and that it encodes a 140-aa protein reported to contain three transmembrane domain (19) which may act as a DNAbinding protein (20)...